TP53 and neoplasm: As a specific inhibitor of Mdm2-p53 interaction, nutlin-3 offers advantages over traditional chemotherapeutic drugs in that, at optimal doses, its apoptotic effect is selective for tumour cells while normal cells undergo reversible cell cycle arrest [48].